Search Results - Jakobsson, Protik

  • Showing 1 - 3 results of 3
Refine Results
  1. 1
    Rituximab versus fingolimod after natalizumab in multiple sclerosis patients

    Rituximab versus fingolimod after natalizumab in multiple sclerosis patients by Alping, Peter, Frisell, Thomas, Novakova, Lenka, Islam-Jakobsson, Protik, Salzer, Jonatan, Björck, Anna, Axelsson, Markus, Malmeström, Clas, Fink, Katharina, Lycke, Jan, Svenningsson, Anders, Piehl, Fredrik

    Published in Annals of neurology
    Get full text
    Items that this one cites
    Items that cite this one
    Article
    Save to List
    Saved in:
  2. 2
    Cerebrospinal Fluid Biomarkers of Synaptic Dysfunction are Altered in Parkinson's Disease and Related Disorders

    Cerebrospinal Fluid Biomarkers of Synaptic Dysfunction are Altered in Parkinson's Disease and Related Disorders by Nilsson, Johanna, Constantinescu, Julius, Nellgård, Bengt, Jakobsson, Protik, Brum, Wagner S., Gobom, Johan, Forsgren, Lars, Dalla, Keti, Constantinescu, Radu, Zetterberg, Henrik, Hansson, Oskar, Blennow, Kaj, Bäckström, David, Brinkmalm, Ann

    Published in Movement disorders
    Get full text
    Items that this one cites
    Items that cite this one
    Article
    Save to List
    Saved in:
  3. 3
    Superior efficacy and tolerability of rituximab as compared to fingolimod for MS patients switching from natalizumab due to positive JC virus serology

    Superior efficacy and tolerability of rituximab as compared to fingolimod for MS patients switching from natalizumab due to positive JC virus serology by Alping, P., Islam-Jakobsson, Protik, Novakova, L., Salzer, Jonatan, Björck, A., Axelsson, M., Malmeström, C., Fink, K., Frisell, T., Lycke, J., Svenningsson, Anders, Piehl, F.

    Published in Multiple sclerosis
    Get full text
    Article
    Save to List
    Saved in:

Search Tools: